Akkermansia vs Ovagen
A side-by-side research comparison of Akkermansia and Ovagen across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Akkermansia | Ovagen |
|---|---|---|
| Full name | Akkermansia muciniphila (Pasteurized) | Ovagen (Liver & GI Peptide Bioregulator) |
| Category | Gut Health | Gut Health |
| Status | Novel food / Supplement | Research compound (peptide bioregulator) |
| Mechanism | Amuc_1100 outer membrane protein activates TLR2 signaling, strengthening gut barrier and improving metabolic endotoxemia. Stimulates mucin production by goblet cells. Enhances GLP-1 secretion and improves insulin signaling. | As a signal peptide, it is proposed to regulate gene expression in hepatic and gastrointestinal tissue, supporting protein synthesis, detoxification pathways, and gut-associated immune function. |
| Molecular weight | Whole organism (not applicable) | ~ (short peptide) |
| Half-life | Colonizes mucus layer; effects persist with continued use | Short (peptide) |
| Bioavailability | Oral - pasteurized form survives transit; live form colonizes | Oral (encapsulated) or subcutaneous |
| Typical dose | 10 billion CFU (pasteurized) or 100mg membrane extract | ~1-2 capsules/day or short injectable courses |
| Frequency | Daily | Once daily |
| Route | Oral capsule | Oral capsule or subcutaneous |
Akkermansia reported benefits
- Improved metabolic markers
- Reduced insulin resistance
- Gut barrier strengthening
- Weight management support
- Reduced systemic inflammation
- Enhanced GLP-1 secretion
Ovagen reported benefits
- Liver function support
- Gastrointestinal tissue support
- Protein synthesis support (proposed)
- Gut-immune resilience
- Short course-based protocol
Related comparisons
Research and educational reference only. Not medical advice.